BiomX (PHGE) Net Equity Issued and Repurchased (2018 - 2025)

BiomX has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $996000.0 in Q1 2025.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $996000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $996000.0 (changed N/A YoY) and the FY2025 annual result came in at $996000.0, down 95.32% from the prior year.
• Net Equity Issued and Repurchased slipped to $996000.0 in Q1 2025 per PHGE's latest filing, from $50.0 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $50.0 million in Q1 2024 and troughed at -$18000.0 in Q2 2022.
• A 5-year average of $7.1 million and a median of $996000.0 in 2025 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2022 and 2023: Net Equity Issued and Repurchased slumped 102.25% in 2022, then soared 33522.22% in 2023.
• Over 5 years, Net Equity Issued and Repurchased stood at $53000.0 in 2021, then slumped by 133.96% to -$18000.0 in 2022, then jumped by 33522.22% to $6.0 million in 2023, then soared by 731.12% to $50.0 million in 2024, then slumped by 98.01% to $996000.0 in 2025.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $996000.0, $50.0 million, and $6.0 million for Q1 2025, Q1 2024, and Q2 2023 respectively.